AVDL: Avadel Pharmaceuticals plc Stock

by  •  • Comments Off on AVDL: Avadel Pharmaceuticals plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 688.97
Enterprise Value ($M) 674.74
Book Value ($M) 73.85
Book Value / Share 0.76
Price / Book 9.33
NCAV ($M) 43.82
NCAV / Share 0.45
Price / NCAV 15.72

Profitability (mra)
Return on Invested Capital (ROIC) -0.43
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.62

Liquidity (mrq)
Quick Ratio 2.33
Current Ratio 2.75

Balance Sheet (mrq) ($M)
Current Assets 134.21
Assets 164.24
Liabilities 90.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 169.12
Operating Income -42.40
Net Income -48.83
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -46.91
Cash from Investing 51.78
Cash from Financing 15.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Janus Henderson Group Plc 14.60 5.65
11-14 13G/A Rtw Investments, Lp 0.00 -100.00
11-13 13G/A Polar Capital Holdings Plc 4.99 -28.85
11-13 13G/A Cowen And Company, Llc 0.00 -100.00
11-08 13G BlackRock, Inc. 5.50 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 147,735 1,028,226 14.37
2025-04-10 235,174 985,245 23.87
2025-04-09 290,442 1,686,798 17.22
2025-04-08 431,245 3,013,824 14.31
2025-04-07 161,900 1,045,216 15.49

(click for more detail)

Similar Companies
AUPH – Aurinia Pharmaceuticals Inc. AURA – Aura Biosciences, Inc.
AVBP – ArriVent BioPharma, Inc. AVTE – Aerovate Therapeutics, Inc.
AXSM – Axsome Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io